Tissue levels of polyunsaturated fatty acids during early human development

Area of Science:

• Biochemistry
• Neuroscience
• Pediatrics

Background:

• Long-chain fatty acids (LCFAs) are crucial for infant development, particularly in the brain.
• Docosahexaenoic acid (DHA) and arachidonic acid (AA) are key polyunsaturated fatty acids (PUFAs) in the central nervous system.

Purpose of the Study:

• To analyze LCFA composition in infant tissues, focusing on brain development.
• To investigate the impact of nutrition, including total parenteral nutrition (TPN) and formula feeding, on fatty acid profiles in infants, especially preterm infants.

Main Methods:

• Analysis of long-chain fatty acids in various infant tissues.
• Comparison of fatty acid profiles in infants with different nutritional histories (TPN, formula feeding) and gestational ages.

Main Results:

• Total n-3, n-6 PUFAs, and n-9 monounsaturated fatty acids increased in the whole forebrain up to 2 years of age.
• The DHA/AA ratio was abnormal in the liver but normal in the brain of neonates on short-term TPN.
• Preterm infants, particularly those fed formulas with high linoleate/alpha-linolenate ratios, exhibited lower DHA levels and DHA/AA ratios in the brain and retina.

Conclusions:

• Infant brain fatty acid composition changes significantly during development.
• Preterm infants are particularly vulnerable to dietary fatty acid imbalances, potentially impacting neurological development.
• Nutritional strategies must consider adequate LCFA intake for optimal infant brain and retinal development, especially in preterm infants.